Each year, millions of people suffer from traumatic tissue damage due to cancers, congenital defects or injury. Biofabrication is the rapid 3D printing of replacement tissue and organs that are customised to the specific needs of the patient. This future of manufacturing technology is set to revolutionise regenerative medicine and deliver high quality health outcomes. The Biomaterials and Tissue Morphology group is a world class multi-disciplinary research team focused on embedding biofabrication into routine clinical use.

Based at our state-of-the-art labs at the QUT Institute of Health and Biomedical Innovation and at the Science and Engineering Faculty, our research has generated new knowledge on tissue-scaffold interaction leading to next generation technology development. Our pre-clinical studies have demonstrated the success of our biofabrication approach to tissue engineering in vivo. With continued intensive research, we aim to translate this revolutionary technology from the laboratory into routine clinical use.